Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Latent Mycobacterium tuberculosis Infection | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to
previously acquired Mycobacterium tuberculosis infection without clinical evidence of active …

Identification and treatment of latent tuberculosis infection (LTBI) can substantially reduce
the risk of developing active disease. However, there is no diagnostic gold standard for LTBI …

There are 9 million cases of active tuberculosis reported annually; however, an estimated
one-third of the world's population is infected with Mycobacterium tuberculosis and remains …

Latent tuberculosis infection (LTBI), defined as a state of persistent immune response to
prior-acquired Mycobacterium tuberculosis antigens without evidence of clinically …

Drug-resistant tuberculosis is a major public health concern in many countries. Over the past
decade, the number of patients infected with Mycobacterium tuberculosis resistant to the …

Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are currently the two main
causes of death among infectious diseases. There is an increasing number of studies trying …

Background Tackling tuberculosis requires testing and treatment of latent tuberculosis in
high-risk groups. The aim of this study was to estimate the predictive values of the tuberculin …

A granuloma is defined as an inflammatory mononuclear cell infiltrate that, while capable of
limiting growth of Mycobacterium tuberculosis, also provides a survival niche from which the …